Kexing Biopharm's Sorafenib Generic Receives Approvals in Egypt and Peru

By SquaredTown on September 30, 2025

SHENZHEN, China, Sept. 30, 2025 /PRNewswire/ -- Kexing Biopharm announced that its in-licensed Sorafenib Tosylate Tablets generic, from Yabao Pharmaceutical Co., Ltd. Beijing, has recently been approved for marketing in both Egypt and Peru, marking another important step in the Kexing's...

Read More